Active options: NVDA TSLA AAPL AMD BA AMZN MARA PLTR BABA MSFT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
NVIDIA (NVDA) healthcare vertical already a $1bn+ business - JPMorgan
January 9, 2024 2:10 PM ESTJPMorgan's Harian Sur maintained an Overweight rating on NVIDIA (NASDAQ: NVDA) in a note Tuesday, saying the company's healthcare vertical is already a $1 billion+ business.
The company's healthcare business is driven by the increasing computational demand for AIdrug discovery, genomics, patient... More
